PRESS RELEASE published on 08/15/2023 at 07:25, 2 years 9 months ago Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
PRESS RELEASE published on 07/18/2023 at 12:26, 2 years 10 months ago Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 06/30/2023 at 07:15, 2 years 10 months ago Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
PRESS RELEASE published on 06/26/2023 at 17:31, 2 years 10 months ago Spexis announces the results of its Annual General Meeting 2023
PRESS RELEASE published on 06/07/2023 at 07:30, 2 years 11 months ago Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
PRESS RELEASE published on 05/30/2023 at 07:15, 2 years 11 months ago Spexis provides business update and announces financial results for the full year 2022
PRESS RELEASE published on 04/28/2023 at 07:20, 3 years ago Spexis has received temporary approval of an extension until 31 of May 2023 for the disclosure obligation in connection with the publication and the filing of the annual report 2022.
PRESS RELEASE published on 04/18/2023 at 07:15, 3 years 1 month ago Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
PRESS RELEASE published on 02/08/2023 at 07:20, 3 years 3 months ago Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®
PRESS RELEASE published on 01/25/2023 at 12:56, 3 years 3 months ago Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
Published on 05/21/2026 at 23:00, 7 hours 30 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 7 hours 30 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 7 hours 30 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 8 hours 15 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 05:10, 1 hour 20 minutes ago ZPMC Launches Automated Production Line for Compact Enclosures
Published on 05/22/2026 at 04:50, 1 hour 40 minutes ago ZPMC Highlights Marine Engineering and Steel Bridge Manufacturing Capabilities on Media Open Day
Published on 05/22/2026 at 04:40, 1 hour 50 minutes ago Xinhua Silk Road: Anhui launches innovation and entrepreneurship contest to attract global sci-tech talents
Published on 05/22/2026 at 03:05, 3 hours 25 minutes ago BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
Published on 05/22/2026 at 02:40, 3 hours 50 minutes ago ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 17:45, 12 hours 45 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 12 hours 45 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 13 hours 55 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
